Cerebral Palsy - References

• Topic Overview
• Health Tools
• Cause
• Symptoms
• What Happens
• What Increases Your Risk
• When To Call a Doctor
• Exams and Tests
• Treatment Overview
• Prevention
• Home Treatment
• Medications
• Surgery
• Other Places To Get Help
• Related Information
• References
• Credits

Citations

1. 
   Palmer FB, Hoon AH (2011). Cerebral palsy. In M Augustyn et al., eds., The Zuckerman Parker Handbook of Developmental and Behavioral Pediatrics for Primary Care, 3rd ed., pp. 164-171. Philadelphia: Lippincott Williams and Wilkins.
   
2. 
   Hoon AH Jr, Tolley F (2013). Cerebral palsy. In ML Batshaw et al., eds., Children With Disabilities, 7th ed., pp. 423-450. Baltimore: Paul H Brookes Publishing.
   

Other Works Consulted

• 
  Ade-Hall RA, Moore AP (2000). Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy. Cochrane Database of Systematic Reviews (1). Oxford: Update Software.
  
• 
  Anttila H, et al. (2008). Effectiveness of physical therapy interventions for children with cerebral palsy: A systematic review. BMC Pediatrics, 8(14): 1-10.
  
• 
  Ashwal S, et al. (2004). Practice parameter: Diagnostic assessment of the child with cerebral palsy. Neurology, 62(6): 851-863.
  
• 
  Bernard TJ, et al. (2012). Neurologic and muscular disorders. In WW Hay Jr et al., eds., Current Diagnosis and Treatment: Pediatrics, 21st ed., pp. 740-829. New York: McGraw-Hill.
  
• 
  Committee on Children with Disabilities, American Academy of Pediatrics (1999, reaffirmed 2010). The treatment of neurologically impaired children using patterning. Pediatrics, 104(5): 1149-1151.
  
• 
  Delgado MR, et al. (2010). Practice parameter: Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology, 74(4): 336-343.
  
• 
  Desch LW (2013). Assistive technology. In ML Batshaw et al., eds., Children With Disabilities, 7th ed., pp. 641-656. Baltimore: Paul H Brookes Publishing.
  
• 
  Diamond M, Armento M (2010). Children with disabilities. In WR Frontera, ed., DeLisa's Physical Medicine and Rehabilitation, vol. 2, pp. 1475-1502. Philadelphia: Lippincott Williams and Wilkins.
  
• 
  Glader L, Tilton A (2009). Cerebral palsy. In WB Carey et al., eds., Developmental-Behavioral Pediatrics, 4th ed., pp. 653-662. Philadelphia: Saunders Elsevier.
  
• 
  Hoare BJ, et al. (2010). Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (Update). Cochrane Database of Systematic Reviews (1).
  
• 
  Murphy NA, et al. (2008, reaffirmed 2012). American Academy of Pediatrics clinical report: Promoting the participation of children with disabilities in sports, recreation, and physical activities. Pediatrics, 121(5): 1057-1061.
  
• 
  Rapin I (2010). Disorders of motor and mental development. In LP Rowland, TA Pedley, eds., Merritt's Neurology, 12th ed., pp. 568-574. Philadelphia: Lippincott Williams and Wilkins.
  
• 
  Renshaw TS, Deluca PA (2006). Cerebral palsy. In RT Morrissy, SL Weinstein, eds., Lovell and Winter's Pediatric Orthopaedics, 6th ed., vol. 1, pp. 551-603. Philadelphia: Lippincott Williams and Wilkins.
  
• 
  Simpson DM, et al. (2008). Assessment: Botulinum neurotoxin for the treatment of spasticity (and evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology, 70(19): 1691-1698.
  

In this article